Relation between expression of α1-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms

Scandinavian Journal of Urology and Nephrology

Volumn 45, Issue 1, 2011, Pages 15-19

  Kurizaki, Yoshiki ^a   Ishizuka, Osamu ^a   Imamura, Tetsuya ^a   Ichino, Midori ^a   Ogawa, Teruyuki ^a   Igawa, Yasuhiko ^a   Nishizawa, Osamu ^a   Andersson, Karl Erik ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

A1 Adrenergic receptor; benign prostatic hyperplasia; International Prostate Symptom Score; overactive bladder

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; MESSENGER RNA;

AGED; ARTICLE; BLADDER MUCOSA; BLADDER WALL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; NUCLEOTIDE SEQUENCE; OVERACTIVE BLADDER SYMPTOM SCORE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; URINE VOLUME; URODYNAMICS; UROTHELIUM; VIDEORECORDING;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; BIOLOGICAL MARKERS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSTATIC HYPERPLASIA; RECEPTORS, ADRENERGIC, ALPHA-1; RETROSPECTIVE STUDIES; RNA, MESSENGER; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, OVERACTIVE; URODYNAMICS; UROLOGIC DISEASES;

EID: 79951623476     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365599.2010.515611     Document Type: Article

References (29)

1. Caine M, Pfau A, Perlberg S. The use of alpha adrenergic blockers in benign prostatic obstruction. Br J Urol 1976;48:255-63.
2. Andersson KE. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alphaadrenoceptor antagonists. World J Urol 2002;19:390-6.
3. Andersson KE. LUTS treatment: future treatment options. Neurourol Urodyn 2007;26:934-47.
4. Kawabe K, Yoshida M, Homma Y. Silodosin Clinical Study Group. Silodosin, a new a1-adreneroreceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized placebo-controlled, double-blind study in Japanese men. BJU Int 2006;98:1019-24. (Pubitemid 44536452)
5. Takahashi S, Tajima A, Matsushima H, Kawamura T, Tominaga T, Kitamura T. Clinical efficacy of an alpha1A/D-adrenoreceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia. Int J Urol 2006;13:15-20.
6. Das AK, Leggett RE, Whitbeck C, Eagan G, Levin RM. Effect of doxazosin on rat urinary bladder function after partial outlet obstruction. Neurourol Urodyn 2002;21:160-66. (Pubitemid 34195210)
7. Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE Urodynamic evaluation of fesoterodine, doxazosin and their combination in a rat model of partial urethral obstruction. BJU Int 2009 [Epub].
8. Andersson KE. Prostatic and extraprostatic alphaadrenoceptors - contributions to the lower urinary tract symptoms in benign prostatic hyperplasia. Scand J Urol Nephrol 1996;179:105-11.
9. Andersson KE, Gratzke C. Pharmacology of alpha 1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 2007;4:368-78. (Pubitemid 47307620)
10. Ishihama H, Momota Y, Yanase H, Wang X, de Groat WC, Kawatani M. Activation of a1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol 2006;175:358-64. (Pubitemid 41797203)
11. Malloy BJ, Price DT, Price RR, Bienstock AM, Dole MK, Funk BL, et al. Alpha1-adrenergic receptor subtypes in human detrusor. J Urol 1998;160:937-43. (Pubitemid 29479558)
12. Hampel C, Dolber PC, Smith MP, Savic SL, Thüroff JW, Thor KB, et al. Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction. J Urol 2002;167:1513-21. (Pubitemid 34132142)
13. Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 2003;170:649-53. (Pubitemid 36870277)
14. Sigala S, Peroni A, Mirabella G, Fornari S, Palazzolo F, Pezzotti G, et al. Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. Life Sci 2004;76:417-27. (Pubitemid 39458310)
15. Chen Q, Takahashi S, Zhong S, Hosoda C, Zheng HY, Ogushi T, et al. Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor. J Urol 2005;174:370-4. (Pubitemid 40825760)
16. Bouchelouche K, Andersen L, Alvarez S, Nordling J, Bouchelouche P. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin. J Urol 2005;173:657-61.
17. Chen Z, Ishizuka O, Imamura T, Aizawa N, Igawa Y, Nishizawa O, et al. Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats. Neurourol Urodyn 2009;28:251-6.
18. Dmitrieva N, Zhang G, Nagabukuro H. Increased alpha1D adrenergic receptor activity and protein expression in the urinary bladder of aged rats. World J Urol 2008;26:649-55.
19. Barendrecht MM, Frazier EP, Vrydag W, Alewijnse AE, Peters SL, Michel MC. The effect of bladder outlet obstruction on alpha1-and beta-adrenoceptor expression and function. Neurourol Urodyn 2009;28:349-55.
20. Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 1999;79:447-54. (Pubitemid 29213362)
21. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome - Overactive Bladder Symptom Score. Urology 2006;68:318-23. (Pubitemid 44175525)
22. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardization of terminology in lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78. (Pubitemid 34195211)
23. Wyndaele JJ. The normal pattern of perception of bladder filling during cystometry studied in 38 young healthy volunteers. J Urol 1998;160:479-81. (Pubitemid 29476702)
24. Wyndaele JJ, De Wachter S. Cystometrical sensory data from a normal population: comparison of two groups of young healthy volunteers examined with 5 years interval. Eur Urol 2002;42:34-8. (Pubitemid 35339642)
25. Lowe FC. Role of the newer alpha-adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms. Clin Ther 2004;26:1701-13. (Pubitemid 40089486)
26. Yanase H, Wang X, Momota Y, Nimura T, Kawatani M. The involvement of urothelial alpha 1A adrenergic receptors in controlling the micturition reflex. Biomed Res 2008;29:239-44.
27. De Wachter S, Van Meel TD, Wyndaele JJ. Can a faked cystometry deceive patients in their perception of filling sensations? A study on the reliability of spontaneously reported cystometric filling sensations in patients with non-neurogenic lower urinary dysfunction. Neurourol Urodyn 2008;27:395-98. (Pubitemid 351991202)
28. Ukimura O, Kanazawa M, Fujihara A, Kamoi K, Okihara K, Miki T. Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: a prospective randomized controlled study. Int J Urol 2008;15:1049-54.
29. Ekström B, Andersson KE, Mattiasson A. Urodynamic effects of intravesical instillation of atropine and phentolamine in patients with detrusor hyperactivity. J Urol 1993;149:155-8. (Pubitemid 23095502)